A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease

NCT05331300 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Fibrosis
Thyroid Eye Disease

Interventions

DRUG: LASN01
DRUG: LASN01
DRUG: Placebo
DRUG: Placebo

Sponsor

Lassen Therapeutics 1 PTY LTD